Will the Pfizer Moderna AstraZeneca COVID-19 vaccines end the pandemic?

Pfizer Moderna AstraZeneca COVID-19 vaccines

There has been a lot of excitement lately with the Pfizer/BioNTech, Moderna, and AstraZeneca/Oxford COVID-19 vaccines lately, but I wanted to temper your enthusiasm thinking the pandemic is going to be over in a few weeks, and we can all hit the pub, drinking with our friends, family, and neighbors. 

If anything, I would strongly recommend wearing a face mask across the world until a substantial number of people are vaccinated, and that may take a lot longer than you thought. By the way, more recent scientific evidence supports the FACT that when both individuals are masked, there is almost no transmission of viruses. 

So, let me explain why, despite the good news, we still need to protect ourselves from the coronavirus. There is light at the end of the tunnel, but don’t be confused by the recent announcements by Pfizer, AstraZeneca, and Moderna regarding their COVID-19 vaccines – there is still a lot of hard work to be done.

Continue reading “Will the Pfizer Moderna AstraZeneca COVID-19 vaccines end the pandemic?”

AstraZeneca COVID-19 vaccine shows 70% effectiveness in phase 3

astrazeneca COVID-19 vaccine

AstraZeneca has announced that its COVID-19 vaccine has exhibited over 70% average effectiveness in phase 3 clinical trials in Brazil and the United Kingdom. The vaccine was initially developed by the University of Oxford, but AstraZeneca will manufacture and distribute the vaccine worldwide.

The AstraZeneca COVID-19 vaccine is the third vaccine over the past few days that has shown extremely high effectiveness following the ones announced by Pfizer and Moderna. However, the AstraZeneca/Oxford vaccine is substantially different in pharmacology and distribution than the other two. 

Continue reading “AstraZeneca COVID-19 vaccine shows 70% effectiveness in phase 3”

COVID-19 vaccine candidates in phase 3 clinical trials – the official list

COVID-19 vaccine candidates

Keeping up with COVID-19 vaccine candidates in clinical trials has gotten out of hand, so keeping up with these clinical trials have become almost impossible. For brevity, I have made the editorial decision to update this list to include just those vaccines in phase 3 clinical trials, which means that they are within the final stages of clinical assessment.

Recently, the World Health Organization (WHO) has listed over 200 COVID19 vaccine candidates, which is amazing, but it is still too difficult to tell which ones will be successful or not without reviewing the actual data. Just because it’s in a phase 3 trial does not mean it will work.

Right now, there are nearly 50 COVID-19 vaccine candidates in phase 1, 2, or 3 clinical trials – this article will only focus on those in phase 3.

Continue reading “COVID-19 vaccine candidates in phase 3 clinical trials – the official list”

COVID19 vaccine clinical trials – over 30 candidates being tested on humans

COVID19 vaccine

This article about COVID19 vaccine trials will be regularly updated as new clinical trials are registered or early results are published about an ongoing trial. Again, this article will focus on COVID19 vaccine trials – treatments and diagnostic tests are outside of the scope of this article.

Keeping up with COVID19 vaccine candidates has gotten out of hand, so for brevity, I’ve created a separate list of coronavirus vaccine trials. The interest in clinical trials for a new COVID19 vaccine is unprecedented, so I thought this might be the best way to keep loyal readers up-to-date.

Recently, the World Health Organization (WHO) has listed over 140 COVID19 vaccine candidates, which is amazing, but it is way too difficult to tell which ones have any chance of actually becoming a real product.

Right now, there are at least 30 COVID19 vaccine candidates in clinical trials – this article will analyze these coronavirus vaccine trials. Every single day, a new COVID19 vaccine candidate enters clinical trials, so this may be out of date within a few hours! 

Continue reading “COVID19 vaccine clinical trials – over 30 candidates being tested on humans”

FluMist vaccine recommendation – CDC gets the science right

FluMist vaccine recommendation

There are a lot of anti-vaccine tropes about the CDC (Centers for Disease Control and Prevention), none of which make a lot of sense. There’s the conspiracy theories that the CDC is bought off by Big Pharma. Or the CDC whistleblower meme that they hid evidence that vaccines cause autism. However, the CDC usually gets the science right, like they did with the recent FluMist vaccine recommendation.

The CDC, a federal government agency made up of scientists, physicians, and public health officers, who come from civilian and military backgrounds, are the first responders to almost any infectious disease outbreak across the world. They are the front line of science against disease.

They use scientific data, gathered through clinical trials or lab experiments, to make public recommendations about diagnosing, treating and preventing diseases. They’re impartial about their recommendations – they go where the data leads them.

So what’s the story behind the FluMist vaccine recommendation, better yet, non-recommendation? It’s not all that complicated, and it’s clear that the CDC got the science right. Continue reading “FluMist vaccine recommendation – CDC gets the science right”